HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

5- ((3- cyclobutyl- 2,3,4,5- tetrahydro- 1H- 3- benzazepin- 7- yl)oxy)- N- methyl- 2- pyrazinecarboxamide

an H3 receptor antagonist; structure in first source
Also Known As:
GSK 207040; GSK-207040; GSK207040
Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Wilson, David M: 2 articles (01/2009 - 04/2007)
2. Medhurst, Andrew D: 2 articles (01/2009 - 04/2007)
3. Gartlon, Jane E: 1 article (01/2009)
4. Lacroix, Laurent P: 1 article (01/2009)
5. Woolley, Marie L: 1 article (01/2009)
6. Jennings, Carol A: 1 article (01/2009)
7. Reavill, Charlie: 1 article (01/2009)
8. Cluderay, Jane E: 1 article (01/2009)
9. Dawson, Lee A: 1 article (01/2009)
10. Jones, Declan N C: 1 article (01/2009)

Related Diseases

1. Schizophrenia (Dementia Praecox)
2. Neuralgia (Stump Neuralgia)
3. Memory Disorders (Memory Loss)
4. Hyperalgesia
5. Dementia (Dementias)

Related Drugs and Biologics

1. Histamine H3 Antagonists
2. Cholinergic Antagonists (Anticholinergics)
3. Histamine H3 Receptors (Histamine H3 Receptor)
4. Scopolamine (Hyoscine)
5. Norepinephrine (Noradrenaline)
6. Dopamine (Intropin)
7. Capsaicin (Zostrix)
8. Amphetamine (Amfetamine)
9. Acetylcholine (Acetylcholine Chloride)
10. 1- (1- methylethyl)- 4- ((1- (6- (trifluoromethyl)- 3- pyridinyl)- 4- piperidinyl)carbonyl)hexahydro- 1H- 1,4- diazepine